$AMRN No matter what side of the debate you’re on, there’s no reason someone shouldn’t TRY using Vascepa to combat this inflammatory response given it’s low level of side effects. I think @rafunrafun brought up the idea of vaccinated individuals taking V to blunt the effects on the endothelial layer. Even if Prepare-It 2 was a “failure”…the vaccine is different than COVID’s make up (right, scientists?). Can hapless AMRN capitalize on this??? Likely, no. They’ve failed at even selling the CVD indication (pandemic and generic market penetration are not excuses for the fact scripts are DOWN YoY and at pre R-It levels…it’s lack of execution). Which BP will realize the gold mine that awaits? That’s what I await myself. ahajournals.org/action/cook...
2
1
1
1 Like